Science Explorer Interactive view Map
Institution · Zeist · Netherlands

Innovatiefonds Zorgverzekeraars

innovatiefondszorgverzekeraars.nlROR OpenAlex
Research works
1
fractional, all time
Citations
9
6.8 per fractional work
Top-10% rate
43.3%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Innovatiefonds Zorgverzekeraars is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Innovatiefonds Zorgverzekeraars publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Biomedical Ethics and Regulation and Statistical Methods in Clinical Trials.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  3. 3 Biomedical Ethics and Regulation Physiology 0 works
  4. 4 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  5. 5 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.1%not open61.9%

World: 28% of research is openly available.

with international co-authors54.1%domestic only45.9%

World: 19% is written across borders.

How has Innovatiefonds Zorgverzekeraars's research output changed?

2020

Other research institutions in Zeist

All research institutions in Zeist

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.